| JYSB0800073 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2008-06-28 | | Bayer Healthcare LLC | Certificate Issued | 2009-07-31 | view |
| JYSB1500116 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2015-04-24 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2015-10-29 | view |
| CXSL1400060 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(10) | New Drug Application | 2014-07-11 | 神州细胞工程有限公司 | SinoCelltech Ltd | Certificate Issued | 2016-01-14 | view |
| JYSB2101162 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-10 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB1900343 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2019-12-13 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2020-03-06 | view |
| JXSL1100033 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2011-07-07 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Certificate Issued | 2013-01-31 | view |
| JYSB2100026 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-01-22 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | In Review | 2021-01-21 | view |
| JXSS1900047 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2019-08-22 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Vetter Pharma-Fertigung Gmbh & Co KG;Pfizer Canada Inc | Certificate Issued | 2021-12-15 | view |
| JYSB2400250 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-12-04 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JXSL0800019 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2008-08-13 | Baxter S.A. | Baxter SA | Certificate Issued | 2010-12-27 | view |
| JYSB2000404 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-08-21 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | Filed | 2020-09-01 | view |
| JYSB2101169 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-25 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB2400051 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2024-03-07 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB1400239 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2014-12-09 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2015-06-19 | view |
| JYSB2101161 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2021-11-10 | | Baxalta Manufacturing Sàrl;Takeda Manufacturing Austria AG | | | view |
| JYSB1600144 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2016-08-05 | | Bayer Healthcare LLC | Certificate Issued | 2018-06-15 | view |
| JYSB1200215 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2012-08-27 | 拜耳医药保健有限公司 | Bayer Healthcare Company Ltd;Bayer Healthcare LLC | Approval Completed-Pending Certificated | | view |
| JXSL0900046 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Import Drug Application | 2009-07-01 | | Bayer Healthcare LLC | Certificate Issued | 2011-01-19 | view |
| JYSB2000558 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | Supplementary Application | 2020-11-04 | | Bayer Healthcare LLC | Filed | 2020-11-17 | view |
| JYSZ2200029 | 注射用重组人凝血因子VIII | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products | License Renew | 2022-06-29 | | Pfizer Europe Ma Eeig;Wyeth Farma SA;Pfizer Investment Co Ltd | | | view |
